Skip to main content

Table 2 Lines of treatment

From: Metastatic colorectal cancer prior to expanded RAS assessment: evidence from long-term outcome analysis of a real-life cohort within a dedicated colorectal cancer unit

 

Total (n = 248)

Survivors < 4 years (n = 188)

Long-term survivors (≥ 4 years) (n = 60)

Number of lines of treatment

1

39 (16%)

34 (18%)

5 (8%)

2

63 (25%)

51 (27%)

12 (20%)

3

67 (27%)

52 (28%)

15 (25%)

4

79 (32%)

51 (27%)

28 (47%)